Zuprevo™ (tildipirosin) 18% is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia
haemolytica, Pasteurella multocida, and Histophilus somni in beef and non-lactating dairy cattle, and for the control of
respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD associated with Mannheimia haemolytica,
Pasteruella multocida and Histophilus somni. Contains 180 mg tildipirosin, a semi-synthetic macrolide antibiotic. Ready-to-use
solution. Subcutaneous injection.